EPISODE · Feb 17, 2022 · 15 MIN
PARP Inhibitors
from ASHPOfficial · host American Society of Health-System Pharmacists©
In this episode, we explore the current clinical applications of poly adenosine diphosphate-ribose polymerase (PARP) inhibitors in cancer care, including their role, targeted cancers, and strategies for managing side effects of these agents. We also forecast where these agents may have additional utilization in the future. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
What this episode covers
In this episode, we explore the current clinical applications of poly adenosine diphosphate-ribose polymerase (PARP) inhibitors in cancer care, including their role, targeted cancers, and strategies for managing side effects of these agents. We also forecast where these agents may have additional utilization in the future. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
NOW PLAYING
PARP Inhibitors
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.